We've found
13,253
archived clinical trials in
Arthritis
We've found
13,253
archived clinical trials in
Arthritis
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Updated: 9/25/2017
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Click here to add this to my saved trials
Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis
Updated: 9/27/2017
Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis
Status: Enrolling
Updated: 9/27/2017
Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis
Updated: 9/27/2017
Physical Therapy Versus Internet-Based Exercise Training for Patients With Knee Osteoarthritis
Status: Enrolling
Updated: 9/27/2017
Click here to add this to my saved trials
Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application
Updated: 9/27/2017
Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application
Status: Enrolling
Updated: 9/27/2017
Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application
Updated: 9/27/2017
Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application
Status: Enrolling
Updated: 9/27/2017
Click here to add this to my saved trials
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
Click here to add this to my saved trials
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
Click here to add this to my saved trials
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
Click here to add this to my saved trials
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
Click here to add this to my saved trials
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
Click here to add this to my saved trials
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
Click here to add this to my saved trials
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
Click here to add this to my saved trials
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
Click here to add this to my saved trials
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
Updated: 9/28/2017
An Open-label Randomized Phase 1 Study to Investigate the Pharmacokinetics and Pharmacodynamics of Subcutaneous and Intravenous Administrations of Golimumab to Subjects With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/28/2017
Click here to add this to my saved trials
Spine Quantitative Computed Tomography (QCT)
Updated: 9/29/2017
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Status: Enrolling
Updated: 9/29/2017
Spine Quantitative Computed Tomography (QCT)
Updated: 9/29/2017
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children
Status: Enrolling
Updated: 9/29/2017
Click here to add this to my saved trials
Walking Aids in the Management of Knee Osteoarthritis
Updated: 9/29/2017
Walking Aids in the Management of Obesity-Related Knee Osteoarthritis
Status: Enrolling
Updated: 9/29/2017
Walking Aids in the Management of Knee Osteoarthritis
Updated: 9/29/2017
Walking Aids in the Management of Obesity-Related Knee Osteoarthritis
Status: Enrolling
Updated: 9/29/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
Updated: 10/2/2017
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Click here to add this to my saved trials
Health Outcomes in Rheumatoid Arthritis
Updated: 10/3/2017
Health Outcomes in Rheumatoid Arthritis
Status: Enrolling
Updated: 10/3/2017
Health Outcomes in Rheumatoid Arthritis
Updated: 10/3/2017
Health Outcomes in Rheumatoid Arthritis
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Genetics of Rheumatoid Arthritis
Updated: 10/5/2017
Genetics of Rheumatoid Arthritis: The North American Rheumatoid Arthritis Consortium
Status: Enrolling
Updated: 10/5/2017
Genetics of Rheumatoid Arthritis
Updated: 10/5/2017
Genetics of Rheumatoid Arthritis: The North American Rheumatoid Arthritis Consortium
Status: Enrolling
Updated: 10/5/2017
Click here to add this to my saved trials
Serum and Synovium Protease Inhibitor Levels in Primary and Secondary Osteoarthritic Joints
Updated: 10/6/2017
Evaluation of Serum and Synovium Protease Inhibitor Levels in Primary and Secondary Osteoarthritic Joints, and Comparison for Patients Undergoing Joint Replacement
Status: Enrolling
Updated: 10/6/2017
Serum and Synovium Protease Inhibitor Levels in Primary and Secondary Osteoarthritic Joints
Updated: 10/6/2017
Evaluation of Serum and Synovium Protease Inhibitor Levels in Primary and Secondary Osteoarthritic Joints, and Comparison for Patients Undergoing Joint Replacement
Status: Enrolling
Updated: 10/6/2017
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers
Updated: 10/6/2017
A Phase 1, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers
Status: Enrolling
Updated: 10/6/2017
Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers
Updated: 10/6/2017
A Phase 1, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers
Status: Enrolling
Updated: 10/6/2017
Click here to add this to my saved trials
The Effects of Group Cycling (Spinning®) With Knee Osteoarthritis: A Randomized Control Trial
Updated: 10/13/2017
The Effects of Group Cycling (Spinning®) On Gait and Pain-Related Disability in Persons With Knee Osteoarthritis: A Randomized Control Trial
Status: Enrolling
Updated: 10/13/2017
The Effects of Group Cycling (Spinning®) With Knee Osteoarthritis: A Randomized Control Trial
Updated: 10/13/2017
The Effects of Group Cycling (Spinning®) On Gait and Pain-Related Disability in Persons With Knee Osteoarthritis: A Randomized Control Trial
Status: Enrolling
Updated: 10/13/2017
Click here to add this to my saved trials
Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers
Updated: 10/16/2017
A Phase 1, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of SKI-O-703 in Healthy Volunteers
Status: Enrolling
Updated: 10/16/2017
Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers
Updated: 10/16/2017
A Phase 1, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of SKI-O-703 in Healthy Volunteers
Status: Enrolling
Updated: 10/16/2017
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Updated: 10/17/2017
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Click here to add this to my saved trials